Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.
LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.
3D printing, augmented reality and deep learning algorithms will shape the future of the pharmaceutical supply chain says Dr Bertalan Mesko, the Medical Futurist.
LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.
The EMA has not experienced any concerns with the safety of the 28 biosimilar products it has recommended, according to an information guide published for healthcare professionals.
update - WHO outlines biosimilarity requirements and inspection plan
The WHO has announced plans to extend its prequalification scheme to include cancer biosimilars and says it will pressure industry for fairer prices for all biologics.
WIRB-Copernicus Group (WIRB) and Huron have announced an alliance to support research programs in the face of heightened expectations from industry sponsors.
DermTech, Inc. has announced two new collaborations with pharmaceutical companies and expects more to follow as the demand for personalized, precision medicine increases.
Smithfield Foods Inc. has tasked a new bioscience unit with turning byproducts from its pork business into supplies for regenerative meds and drug firms.
Sandoz and Aurobindo are among drugmakers which will need to provide alternative bioequivalence data after the EMA recommended suspension of medicines tested by Micro Therapeutic Research Labs.
DHL Global Forwarding plans to certify seven US stations in the Americas throughout 2017 with the remaining global stations slated for certification by the end of the second quarter.
The Danish Medicines Agency (DKMA) has cleared Europharma DK ApS to resume drug sales and distribution after the firm appointed a new managing director.
Parexel’s expanded Managed Access Program helps biopharmaceutical companies provide compassionate access to patients as the industry faces an increasing public demand for treatment options.
Czech authorities have ordered B. Braun Medical s.r.o to stop supplying medicines from a warehouse in Rudná after identifying breaches of good distribution practice (GDP) guidelines.
Evotec AG and MaRS Innovation have launched Fibrocor Therapeutics LP – a new company which will focus on developing first-in-class therapeutics targeting fibrotic diseases.
A pool of contractors will compete for task orders as part of the NIAID's preclinical drug development services contract to develop therapeutics for a range of global infectious diseases.
The Gates Foundation has invested $140m in Intarcia Therapeutics Inc to develop the biotech’s needle-free delivery pump for use with an HIV prophylactic therapy.
The EMA has started reviewing drugs tested by Micro Therapeutic Research Labs after an inspection by Dutch and Austrian regulators identified potential data integrity problems.
bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.
Through the collaboration, Purdue will leverage Exicure’s Spherical Nucleic Acid (SNA)™ technology to discover and develop a treatment for psoriasis, and other diseases.
The new collaborative initiative will be led by QuintilesIMS, with founding partners including Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, and Pfizer.
The full-service contract development and manufacturing organization (CDMO) for investigational medicinal products has purchased a new building to expand its high containment manufacturing and development operations.
World Courier is set to open a new Moscow, Russia-based investigational drug depot in August – and it will be nearly six times larger than the current depot.
Purdue Pharma has joined the National Pharmaceutical Council (NPC), a health policy research organization working to advance good evidence and science.
